Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Cancer Epidemiol. 2016 Mar 21;42:46–52. doi: 10.1016/j.canep.2016.03.003

Table 4.

Sensitivity of HPV16 E6 for HPV-driven head and neck cancer, by non-OPC versus OPC.

Non-OPC Tumor Status (N=15)
OPC Tumor Status (N=10)
HPV-Drivena (N=2) HPV-Negativeb (N=13) HPV-Drivena (N=6) HPV-Negativeb (N=4)

HPV16 E6 Serology N (%) N (%) N (%) N (%)
 Seropositive 0 (0.0) 0 (0.0) 6 (100) 0 (0.0)
 Seronegative 2 (100) 13 (100) 0 (0.0) 4 (100)
a

HPV ISH and p16 double positive

b

HPV ISH and p16 double negative